Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Yamashita Dennis — DelMar Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Yamashita Dennis

Yamashita Dennis

Chief Scientific Officer at DelMar Pharmaceuticals, Inc. · on record since Oct 22, 2024

Insider trading activity of Yamashita Dennis

Transactions on record: 1; since Oct 22, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Oct 22, 2024

Figures computed from official regulatory filings — methodology.

Companies where Yamashita Dennis has traded

DelMar Pharmaceuticals, Inc.1 tx · Oct 22, 2024

Track record of Yamashita Dennis

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Yamashita Dennis

Co-insiders of Yamashita Dennis

BACHA JEFFREYDelMar Pharmaceuticals, Inc.
Bahouth Donald G.DelMar Pharmaceuticals, Inc.
Bell John KDelMar Pharmaceuticals, Inc.
BIANCO JAMES ADelMar Pharmaceuticals, Inc.
Brown Dennis MDelMar Pharmaceuticals, Inc.
Cranston Lynda SarahDelMar Pharmaceuticals, Inc.
Dearborn DanDelMar Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Douglass Laura L.DelMar Pharmaceuticals, Inc.

Ferrara NapoleoneDelMar Pharmaceuticals, Inc.

FUGUET HOWARD KDelMar Pharmaceuticals, Inc.

Garner William JDelMar Pharmaceuticals, Inc.

HOFFMAN ROBERTDelMar Pharmaceuticals, Inc.

Liatos JohnDelMar Pharmaceuticals, Inc.

List AlanDelMar Pharmaceuticals, Inc.

MANUSO JAMES S JDelMar Pharmaceuticals, Inc.

Mohr ErichDelMar Pharmaceuticals, Inc.

Murphy KeithDelMar Pharmaceuticals, Inc.

Ng George KDelMar Pharmaceuticals, Inc.

Patel VijayDelMar Pharmaceuticals, Inc.

Praill ScottDelMar Pharmaceuticals, Inc.

SEYMOUR TAMARA ADelMar Pharmaceuticals, Inc.

Tendler CraigDelMar Pharmaceuticals, Inc.

TOTH ROBERT JOSEPH JRDelMar Pharmaceuticals, Inc.

Vollintine Raymond L.DelMar Pharmaceuticals, Inc.

Zarrabian SaiidDelMar Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
DelMar Pharmaceuticals, Inc.	Oct 22, 2024	AwardD	196,790	0.00 USD	$0	SEC